Supplementary Material – Phase II, Clinical Trial of Cabozantinib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplant
收藏DataCite Commons2022-05-03 更新2025-04-15 收录
下载链接：
https://future-science-group.figshare.com/articles/dataset/Supplementary_Material_Phase_II_Clinical_Trial_of_Cabozantinib_for_the_Treatment_of_Recurrent_Hepatocellular_Carcinoma_after_Liver_Transplant/19361033/1
下载链接
链接失效反馈官方服务：
资源简介：
Allowed Therapies Prohibited or Restricted Therapies Biological specimens (Plans for collection, laboratory evaluation, and storage of specimens) Confidentiality Retention of Patient Records and Study Files
提供机构：
Future Science Group
创建时间：
2022-05-03
